BACKGROUND: Because prostate specific antigen (PSA) is released at increased levels into the blood early in the development of prostate cancer, benign prostatic hyperplasia (BPH) and prostatitis, it is widely used as a marker for these diseases. However, PSA has clinical limitations as a screen for prostatic diseases due to its low sensitivity and specificity. There is a strong need to better understand the biology of PSA and factors affecting its serum levels. METHODS: We evaluated cynomolgus macaques, rhesus macaques, baboons, and marmosets for their suitability as models for the study of PSA biology and prostatic diseases. RESULTS: Prostates of several nonhuman primates are anatomically similar to the human counterpart. Anti-human PSA antibody detected PSA antigens in all the Old World monkeys (cynomolgus macaques, rhesus macaques, and baboons) but not in marmosets. Of the Old World monkeys, cynomolgus macaques have the highest serum PSA levels; baboons have the lowest. Serum PSA levels from macaques includes a number of outlier samples with unusually high values. We also report two cases of abnormal pathologies in macaques accompanied by high serum PSA levels. One case consisted of prostatic hyperplasia involving both glandular and basal cells in a cynomolgus macaque and another of glandular hyperplasia and atrophy in a rhesus macaque. The finding that pathological changes in the prostate of macaques may lead to increases in serum PSA is worthy of further exploration. CONCLUSION: Cynomolgus macaques and rhesus macaques are promising animal models for PSA biology studies.
BACKGROUND: Because prostate specific antigen (PSA) is released at increased levels into the blood early in the development of prostate cancer, benign prostatic hyperplasia (BPH) and prostatitis, it is widely used as a marker for these diseases. However, PSA has clinical limitations as a screen for prostatic diseases due to its low sensitivity and specificity. There is a strong need to better understand the biology of PSA and factors affecting its serum levels. METHODS: We evaluated cynomolgus macaques, rhesus macaques, baboons, and marmosets for their suitability as models for the study of PSA biology and prostatic diseases. RESULTS: Prostates of several nonhuman primates are anatomically similar to the human counterpart. Anti-humanPSA antibody detected PSA antigens in all the Old World monkeys (cynomolgus macaques, rhesus macaques, and baboons) but not in marmosets. Of the Old World monkeys, cynomolgus macaques have the highest serum PSA levels; baboons have the lowest. Serum PSA levels from macaques includes a number of outlier samples with unusually high values. We also report two cases of abnormal pathologies in macaques accompanied by high serum PSA levels. One case consisted of prostatic hyperplasia involving both glandular and basal cells in a cynomolgus macaque and another of glandular hyperplasia and atrophy in a rhesus macaque. The finding that pathological changes in the prostate of macaques may lead to increases in serum PSA is worthy of further exploration. CONCLUSION: Cynomolgus macaques and rhesus macaques are promising animal models for PSA biology studies.
Authors: E P Diamandis; G M Yousef; J Clements; L K Ashworth; S Yoshida; T Egelrud; P S Nelson; S Shiosaka; S Little; H Lilja; U H Stenman; H G Rittenhouse; H Wain Journal: Clin Chem Date: 2000-11 Impact factor: 8.327
Authors: Samuel R Denmeade; Carsten M Jakobsen; Samuel Janssen; Saeed R Khan; Elizabeth S Garrett; Hans Lilja; S Brogger Christensen; John T Isaacs Journal: J Natl Cancer Inst Date: 2003-07-02 Impact factor: 13.506
Authors: James N Mubiru; Gene B Hubbard; Edward J Dick; Stephanie D Butler; Anthony J Valente; Dean A Troyer; Jeffrey Rogers Journal: Prostate Date: 2007-09-15 Impact factor: 4.104
Authors: Jacques Halabi; Brett W Jagger; Vanessa Salazar; Emma S Winkler; James P White; Peter A Humphrey; Alec J Hirsch; Daniel N Streblow; Michael S Diamond; Kelle Moley Journal: J Infect Dis Date: 2020-04-07 Impact factor: 5.226
Authors: James N Mubiru; Magdalena Garcia-Forey; Nicole Cavazos; Peggah Hemmat; Edward J Dick; Michael A Owston; Cassondra A Bauer; Robert E Shade; Jeffrey Rogers Journal: Prostate Date: 2011-06-28 Impact factor: 4.104
Authors: Erin E Ball; Patricia A Pesavento; Koen K A Van Rompay; M Kevin Keel; Anil Singapuri; Jose P Gomez-Vazquez; Dawn M Dudley; David H O'Connor; Meghan E Breitbach; Nicholas J Maness; Blake Schouest; Antonito Panganiban; Lark L Coffey Journal: PLoS Negl Trop Dis Date: 2022-07-05
Authors: Kimberley A Phillips; Karen L Bales; John P Capitanio; Alan Conley; Paul W Czoty; Bert A 't Hart; William D Hopkins; Shiu-Lok Hu; Lisa A Miller; Michael A Nader; Peter W Nathanielsz; Jeffrey Rogers; Carol A Shively; Mary Lou Voytko Journal: Am J Primatol Date: 2014-04-10 Impact factor: 2.371
Authors: Darren R Veach; Claire M Storey; Katharina Lückerath; Katharina Braun; Christian von Bodman; Urpo Lamminmäki; Teja Kalidindi; Sven-Erik Strand; Joanna Strand; Mohamed Altai; Robert Damoiseaux; Pat Zanzonico; Nadia Benabdallah; Dmitry Pankov; Howard I Scher; Peter Scardino; Steven M Larson; Hans Lilja; Michael R McDevitt; Daniel L J Thorek; David Ulmert Journal: Clin Cancer Res Date: 2021-01-13 Impact factor: 12.531